Avanos Medical (NYSE:AVNS) is scheduled to be announcing its earnings results before the market opens on Tuesday, August 4th. Analysts expect the company to announce earnings of ($0.08) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.
Avanos Medical (NYSE:AVNS) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. Avanos Medical had a negative net margin of 3.07% and a positive return on equity of 4.09%. The firm had revenue of $180.40 million during the quarter, compared to analyst estimates of $175.15 million. During the same period in the previous year, the business posted $0.15 earnings per share. The business’s revenue for the quarter was up 9.9% on a year-over-year basis. On average, analysts expect Avanos Medical to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Shares of AVNS stock opened at $30.67 on Friday. The company has a 50 day moving average price of $30.11 and a 200-day moving average price of $29.40. Avanos Medical has a 52 week low of $19.46 and a 52 week high of $48.07. The firm has a market capitalization of $1.46 billion, a PE ratio of 28.40, a P/E/G ratio of 4.59 and a beta of 1.19. The company has a quick ratio of 1.96, a current ratio of 2.77 and a debt-to-equity ratio of 0.24.
Several analysts recently issued reports on the stock. KeyCorp cut their target price on shares of Avanos Medical from $48.00 to $45.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Barclays upgraded shares of Avanos Medical from an “underweight” rating to an “equal weight” rating and set a $30.00 target price for the company in a research report on Monday, April 13th. Finally, Morgan Stanley boosted their target price on shares of Avanos Medical from $29.00 to $31.00 and gave the company an “underweight” rating in a research report on Thursday, May 7th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $37.43.
Avanos Medical Company Profile
Avanos Medical, Inc operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.
Recommended Story: Which market index is the best?
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.